Early Detection of Lung Cancer

Study summary

This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedBiospecimen Collection and Biospecimen collection

Plus 6 other study approaches.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 5, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Vanderbilt-Ingram Cancer Center

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: Vanderbilt-Ingram Cancer Center
Interventions being studied: Procedure: Biospecimen Collection; Procedure: Biospecimen collection; Procedure: Biospecimen collection; Procedure: Biospecimen collection; Procedure: Biospecimen collection; Procedure: Pulmonary Function Test; Procedure: Computed Tomography (CT); Other: Laboratory Biomarker

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Current smoker or former smoker, if former smoker participants must have quit smoking within the past 15 years
\>= 30 pack year of smoking history
Participant is uninsured

Reasons someone may not be able to joinExclusion criteria

History of diagnosis/treatment of lung cancer in the past 2 years
History of head/neck or esophageal cancer in the last 1 year
Inability to provide informed consent

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Vanderbilt-Ingram Cancer CenterNashville, Tennessee

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 5, 2026. Always confirm current availability with the study team.

View original record ↗